Cargando…
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin
BACKGROUND: Chronic hepatitis C virus (HCV) infection is associated with impairment of cognitive function and mood disorders. Our aim was to evaluate the impact of sustained virological response (SVR) on cognitive function and mood disorders. METHOD: A prospective exploratory one arm study was condu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702148/ https://www.ncbi.nlm.nih.gov/pubmed/29178838 http://dx.doi.org/10.1186/s12876-017-0679-5 |
_version_ | 1783281466098057216 |
---|---|
author | Barbosa, Mary Ellen Dias Zaninotto, Ana Luiza de Campos Mazo, Daniel Ferraz Pessoa, Mario Guimarães de Oliveira, Cláudia Pinto Marques Souza Carrilho, Flair José Farias, Alberto Queiroz |
author_facet | Barbosa, Mary Ellen Dias Zaninotto, Ana Luiza de Campos Mazo, Daniel Ferraz Pessoa, Mario Guimarães de Oliveira, Cláudia Pinto Marques Souza Carrilho, Flair José Farias, Alberto Queiroz |
author_sort | Barbosa, Mary Ellen Dias |
collection | PubMed |
description | BACKGROUND: Chronic hepatitis C virus (HCV) infection is associated with impairment of cognitive function and mood disorders. Our aim was to evaluate the impact of sustained virological response (SVR) on cognitive function and mood disorders. METHOD: A prospective exploratory one arm study was conducted. Adult clinically compensated HVC patients were consecutively recruited before treatment with interferon and ribavirin for 24 to 48 weeks, according to HCV genotype. Clinical, neurocognitive and mood assessments using the PRIME-MD and BDI instruments were performed at baseline, right after half of the expected treatment has been reached and 6 months after the end of antiviral treatment. Exclusion criteria were the use of illicit psychotropic substances, mental confusion, hepatic encephalopathy, hepatocellular carcinoma, severe anemia, untreated hypothyroidism, Addison syndrome and major depression before treatment. RESULTS: Thirty six patients were enrolled and 21 completed HCV treatment (n = 16 with SVR and n = 5 without). Regardless of the viral clearance at the end of treatment, there was a significant improvement in the immediate verbal episodic memory (p = 0.010), delayed verbal episodic memory (p = 0.007), selective attention (p < 0.001) and phonemic fluency (p = 0.043). Patients with SVR displayed significant improvement in immediate (p = 0.045) and delayed verbal episodic memory (p = 0.040) compared to baseline. The baseline frequency of depression was 9.5%, which rose to 52.4% during treatment, and returned to 9.5% 6 months after the end of treatment, without significant difference between patients with and without SVR. Depressive symptoms were observed in 19.1% before treatment, 62% during (p = 0.016) and 28.6% 6 months after the end of treatment (p = 0.719). CONCLUSIONS: Eradication of HCV infection improved cognitive performance but did not affect the frequency of depressive symptoms at least in the short range. |
format | Online Article Text |
id | pubmed-5702148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57021482017-12-04 Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin Barbosa, Mary Ellen Dias Zaninotto, Ana Luiza de Campos Mazo, Daniel Ferraz Pessoa, Mario Guimarães de Oliveira, Cláudia Pinto Marques Souza Carrilho, Flair José Farias, Alberto Queiroz BMC Gastroenterol Research Article BACKGROUND: Chronic hepatitis C virus (HCV) infection is associated with impairment of cognitive function and mood disorders. Our aim was to evaluate the impact of sustained virological response (SVR) on cognitive function and mood disorders. METHOD: A prospective exploratory one arm study was conducted. Adult clinically compensated HVC patients were consecutively recruited before treatment with interferon and ribavirin for 24 to 48 weeks, according to HCV genotype. Clinical, neurocognitive and mood assessments using the PRIME-MD and BDI instruments were performed at baseline, right after half of the expected treatment has been reached and 6 months after the end of antiviral treatment. Exclusion criteria were the use of illicit psychotropic substances, mental confusion, hepatic encephalopathy, hepatocellular carcinoma, severe anemia, untreated hypothyroidism, Addison syndrome and major depression before treatment. RESULTS: Thirty six patients were enrolled and 21 completed HCV treatment (n = 16 with SVR and n = 5 without). Regardless of the viral clearance at the end of treatment, there was a significant improvement in the immediate verbal episodic memory (p = 0.010), delayed verbal episodic memory (p = 0.007), selective attention (p < 0.001) and phonemic fluency (p = 0.043). Patients with SVR displayed significant improvement in immediate (p = 0.045) and delayed verbal episodic memory (p = 0.040) compared to baseline. The baseline frequency of depression was 9.5%, which rose to 52.4% during treatment, and returned to 9.5% 6 months after the end of treatment, without significant difference between patients with and without SVR. Depressive symptoms were observed in 19.1% before treatment, 62% during (p = 0.016) and 28.6% 6 months after the end of treatment (p = 0.719). CONCLUSIONS: Eradication of HCV infection improved cognitive performance but did not affect the frequency of depressive symptoms at least in the short range. BioMed Central 2017-11-25 /pmc/articles/PMC5702148/ /pubmed/29178838 http://dx.doi.org/10.1186/s12876-017-0679-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Barbosa, Mary Ellen Dias Zaninotto, Ana Luiza de Campos Mazo, Daniel Ferraz Pessoa, Mario Guimarães de Oliveira, Cláudia Pinto Marques Souza Carrilho, Flair José Farias, Alberto Queiroz Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title | Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title_full | Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title_fullStr | Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title_full_unstemmed | Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title_short | Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
title_sort | hepatitis c virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702148/ https://www.ncbi.nlm.nih.gov/pubmed/29178838 http://dx.doi.org/10.1186/s12876-017-0679-5 |
work_keys_str_mv | AT barbosamaryellendias hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT zaninottoanaluiza hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT decamposmazodanielferraz hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT pessoamarioguimaraes hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT deoliveiraclaudiapintomarquessouza hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT carrilhoflairjose hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin AT fariasalbertoqueiroz hepatitiscviruseradicationimprovesimmediateanddelayedepisodicmemoryinpatientstreatedwithinterferonandribavirin |